Fifth Third Bancorp (FITB) valuation

Share price $49.66 · Close 2026-04-24

Price-to-Earnings

P/E · Trailing Diluted
14.03×
P/E history →

Price-to-Free-Cash-Flow

P/FCF · Trailing
8.50×
P/FCF history →

Free-Cash-Flow Yield

FCF Yield · Trailing
11.77%
FCF Yield history →

Enterprise-Value-to-EBITDA

EV/EBITDA · Trailing
EV/EBITDA history →

Price-to-Sales

P/S · Trailing
53477.33×
P/S history →

Price-to-Book

P/B · Latest filing
1511.47×
P/B history →

Expectations investing: what does the price imply?

Stress figure — solve did not fully reconcile

Rappaport-style reverse-DCF. We start from the current market price ($49.66 × 661.20B shares = $32.84T market cap, $32.85T enterprise value) and solve for the operating path that would justify it.

To reconcile today's price with a plausible scenario, the model lands on:

  • Year-1 revenue growth: 60.0%
    Source is analyst consensus (absolute forecast, TTM-anchored) of 42.4%; the scenario bumped Y1 by +17.6pp and still needed the margin band widened — both levers are at stretch.
  • Target EBIT margin (Y10): 198.0%
    Scenario lands on 198.0% after relaxing the historical bracket (3-yr range 34.4%–517.9%).
  • High-growth plateau: 5 years
    Stretched from the 3-year tier default to 5 — the default couldn't reconcile with today's price.

at or below the reference above the reference outside the historical band

Where the PV comes from
Y1–3
-181%
Y4–10
-72%
Terminal
+353%

Share of the total PV the model has assigned to each window. The further out a cash flow sits, the harder it is to estimate — so readers can weigh how much of the scenario rests on the near, plateau, and post-horizon periods.

Reconciliation gap
−99.6%
DCF PV/share $0.22 vs market $49.66. The solver couldn't fully reconcile; the gap measures how much the stress-band assumptions still fall short.

Facts · FY2025 (2025-12-31)

Share price
$49.66
Diluted shares
661.20B
Total debt
$14.30B
Cash & equivalents
$3.50B
Revenue
$9.02B
Pretax income (cont. ops)
$3.21B
Filer does not tag us-gaap:OperatingIncomeLoss; using pretax income from continuing operations as the operating-income base. For banks this is effectively operating income (interest expense is a core cost); for oil majors and some pharma filers it's a close proxy with small non-operating items mixed in.
Pretax margin
35.6%
Operating cash flow
$4.51B
CapEx
$584.0M
Observed YoY growth
6.3%
Analyst current-FY growth
42.1%
Analyst next-FY growth
7.6%
3-year revenue CAGR
148.3%

Assumptions

Initial revenue growth
42.4%
from analyst consensus (absolute forecast, TTM-anchored)
(analyst FY-over-FY consensus: 42.1% — shown effective rate normalises it against our TTM base, which spans the current FY partway)
Year-2 growth
7.6%
from analyst next-FY consensus
Starting EBIT margin
196.0%
from 3-year mean EBIT margin (latest FY deviates > 5pp)
Tax rate
21.4%
from 3-year median of EffectiveTaxRate
Starting ROIC
7.8%
NOPAT₀ ÷ invested capital, capped at 40.0%

Constants

Horizon
10 years
WACC
9.0%
Terminal growth
2.5%
Terminal ROIC
11.0%

Yearly projection

Year Revenue Growth EBIT Margin NOPAT ROIC Reinvestment FCF Discount PV of FCF
1 $14.43B 60.0% $28.30B 196.2% $22.25B 8.1% $243.94B -$221.70B 0.917 -$203.39B
2 $18.41B 27.6% $36.14B 196.4% $28.41B 8.4% $73.33B -$44.91B 0.842 -$37.80B
3 $23.48B 27.6% $46.16B 196.6% $36.29B 8.7% $90.18B -$53.89B 0.772 -$41.61B
4 $29.96B 27.6% $58.95B 196.8% $46.35B 9.1% $111.05B -$64.70B 0.708 -$45.84B
5 $38.23B 27.6% $75.29B 197.0% $59.19B 9.4% $136.93B -$77.74B 0.650 -$50.53B
6 $46.86B 22.6% $92.38B 197.2% $72.62B 9.7% $138.41B -$65.79B 0.596 -$39.23B
7 $55.08B 17.6% $108.70B 197.4% $85.46B 10.0% $127.97B -$42.51B 0.547 -$23.25B
8 $61.98B 12.5% $122.45B 197.6% $96.26B 10.4% $104.41B -$8.15B 0.502 -$4.09B
9 $66.64B 7.5% $131.79B 197.8% $103.61B 10.7% $68.76B $34.84B 0.460 $16.04B
10 $68.31B 2.5% $135.22B 198.0% $106.30B 11.0% $24.52B $81.78B 0.422 $34.54B
Sum of PV of FCF (years 1-10) -$395.15B

Terminal value

NOPATN+1
$108.96B
ReinvestmentN+1
$24.16B
FCFN+1
$84.80B
Terminal value (undiscounted)
$1.30T
PV of terminal value
$551.09B
Gordon-growth: TV = FCFN+1 ÷ (WACC − g) = $84.80B ÷ (9.0% − 2.5%).

Equity bridge

PV of operating FCF -$395.15B
+ PV of terminal value $551.09B
= Enterprise value $155.93B
− Total debt $14.30B
+ Cash & equivalents $3.50B
= Equity value $145.13B
÷ Diluted shares 661.20B
= DCF PV / share $0.22
Market price $49.66
Reconciliation delta −99.6% (widened band)
Full calculation trail Click to expand — every number on this page derived step by step.

1 · Enterprise-value target (what the DCF must match)

Market cap   = price × diluted shares
             = $49.66 × 661.20B
             = $32.84T

EV target    = market cap + total debt − cash & equivalents
             = $32.84T + $14.30B − $3.50B
             = $32.85T
            

2 · Starting NOPAT (base year 0)

GAAP EBIT          = $3.21B   (35.6% of revenue)
× (1 − tax rate)  = × (1 − 21.4%) = × 0.7861
= NOPAT₀            = $2.52B
            

3 · Invested capital & starting ROIC

Invested capital = total debt + book equity − cash
                 = $14.30B + $21.72B − $3.50B
                 = $32.52B

Raw ROIC₀        = NOPAT₀ / Invested capital
                 = $2.52B / $32.52B
                 = 7.8%
(no cap applied; raw value is within the 40.0% ceiling)
            

4 · Growth path construction

Source       = analyst consensus (absolute forecast, TTM-anchored): Y1 = 42.4%, Y2 = 7.6%
Clamp        = [2.5%, 60%] (no sub-terminal or 60%+ starts)
Plateau rate = 7.6% (Y2 — held from year 2 through end of plateau)
Tier         = 3 years (rule: plateau rate < 15% → 3y, < 25% → 5y, else 7y)
Solver ext.  = 5 years (solver extended to reconcile the DCF with the current price)
Plateau      = 5 years
Fade         = linear from effective Y2 to terminal 2.5% across the remaining 5 years

Effective Y1 growth after solver bumps = 60.0%
Effective Y2 growth after solver bumps = 25.2%
Growth by year:
  Y1 = 60.0%
  Y2 = 27.6%
  Y3 = 27.6%
  Y4 = 27.6%
  Y5 = 27.6%
  Y6 = 22.6%
  Y7 = 17.6%
  Y8 = 12.5%
  Y9 = 7.5%
  Y10 = 2.5%
            

5 · Margin path construction

Starting margin (Y0) = 196.0%   (source: 3-year mean EBIT margin (latest FY deviates > 5pp))
Target margin (Y10)  = 198.0%   (solver output, widened band)
Year-t margin        = starting + (target − starting) × (t / 10)
Margin by year:
  Y1 = 196.2%
  Y2 = 196.4%
  Y3 = 196.6%
  Y4 = 196.8%
  Y5 = 197.0%
  Y6 = 197.2%
  Y7 = 197.4%
  Y8 = 197.6%
  Y9 = 197.8%
  Y10 = 198.0%
            

6 · ROIC path construction

The capex heuristic compares latest-period CapEx ($584.0M) against the Normalized CapEx (3-yr mean) of $496.3M — mean of the last three annual CapEx values. When the latest is above 1.4× that mean and CapEx is at least 5% of revenue, we treat the filer as capital-intensive and mid-investment, hold ROIC flat for a 5-year harvest phase, and only then fade to terminal ROIC. The 3-yr mean does not feed the DCF directly — it only gates this flag.

Capex-heuristic inactive (latest CapEx 1.18× the 3-yr mean of $496.3M — below the 1.4× / 5%-of-revenue gates).
Fade from Y1: ROIC_t = ROIC₀ + (ROIC_terminal − ROIC₀) × (t / 10)
ROIC₀ = 7.8%; ROIC_terminal = 11.0%

ROIC by year:
  Y1 = 8.1%
  Y2 = 8.4%
  Y3 = 8.7%
  Y4 = 9.1%
  Y5 = 9.4%
  Y6 = 9.7%
  Y7 = 10.0%
  Y8 = 10.4%
  Y9 = 10.7%
  Y10 = 11.0%
            

7 · Solver iterations

Each row is one bisection attempt. The solver sweeps Y1 growth bumps 0pp → +20pp across the plateau ladder inside the normal margin bracket, then — if nothing reconciles — repeats the same sweep in a widened margin band ([-10%, 80%]). The first feasible attempt is the one the page uses. If no combination reconciles, the page shows the attempt whose PV sits closest to the target EV so both levers are balanced.

# Phase Plateau Y1 bump Solved margin PV(EV) vs target Feasible?
1 normal 3y +0pp 198.0% $50.19B −99.8% no
2 normal 3y +2pp 198.0% $54.73B −99.8% no
3 normal 3y +4pp 198.0% $59.79B −99.8% no
4 normal 3y +6pp 198.0% $65.41B −99.8% no
5 normal 3y +8pp 198.0% $71.65B −99.8% no
6 normal 3y +10pp 198.0% $78.55B −99.8% no
7 normal 3y +12pp 198.0% $86.17B −99.7% no
8 normal 3y +14pp 198.0% $94.56B −99.7% no
9 normal 3y +16pp 198.0% $103.79B −99.7% no
10 normal 3y +18pp 198.0% $113.72B −99.7% no
11 normal 3y +20pp 198.0% $123.63B −99.6% no
12 normal 5y +0pp 198.0% $52.64B −99.8% no
13 normal 5y +2pp 198.0% $58.52B −99.8% no
14 normal 5y +4pp 198.0% $65.19B −99.8% no
15 normal 5y +6pp 198.0% $72.72B −99.8% no
16 normal 5y +8pp 198.0% $81.20B −99.8% no
17 normal 5y +10pp 198.0% $90.73B −99.7% no
18 normal 5y +12pp 198.0% $101.40B −99.7% no
19 normal 5y +14pp 198.0% $113.32B −99.7% no
20 normal 5y +16pp 198.0% $126.61B −99.6% no
21 normal 5y +18pp 198.0% $141.13B −99.6% no
22 normal 5y +20pp 198.0% $155.93B −99.5% no
23 widened 3y +0pp 80.0% -$5.81B −100.0% no
24 widened 3y +2pp 80.0% -$1.58B −100.0% no
25 widened 3y +4pp 80.0% $1.33B −100.0% no
26 widened 3y +6pp 80.0% $3.68B −100.0% no
27 widened 3y +8pp 80.0% $5.47B −100.0% no
28 widened 3y +10pp 80.0% $7.20B −100.0% no
29 widened 3y +12pp 80.0% $9.38B −100.0% no
30 widened 3y +14pp 80.0% $11.12B −100.0% no
31 widened 3y +16pp 80.0% $12.76B −100.0% no
32 widened 3y +18pp 80.0% $14.79B −100.0% no
33 widened 3y +20pp 80.0% $17.32B −99.9% no
34 widened 5y +0pp 80.0% -$532.8M −100.0% no
35 widened 5y +2pp 80.0% $3.56B −100.0% no
36 widened 5y +4pp 80.0% $6.51B −100.0% no
37 widened 5y +6pp 80.0% $8.89B −100.0% no
38 widened 5y +8pp 80.0% $11.58B −100.0% no
39 widened 5y +10pp 80.0% $13.54B −100.0% no
40 widened 5y +12pp 80.0% $16.00B −100.0% no
41 widened 5y +14pp 80.0% $19.02B −99.9% no
42 widened 5y +16pp 80.0% $22.67B −99.9% no
43 widened 5y +18pp 80.0% $26.06B −99.9% no
44 widened 5y +20pp 80.0% $29.36B −99.9% no

8 · Terminal value derivation

NOPAT_{N+1}         = NOPAT_{10} × (1 + g_terminal)
                    = $106.30B × (1 + 2.5%)
                    = $108.96B

ΔNOPAT              = NOPAT_{N+1} − NOPAT_{10}
                    = $2.66B
Reinvestment_{N+1}  = ΔNOPAT / ROIC_terminal
                    = $2.66B / 11.0%
                    = $24.16B

FCF_{N+1}           = NOPAT_{N+1} − Reinvestment_{N+1}
                    = $108.96B − $24.16B
                    = $84.80B

Terminal value (TV) = FCF_{N+1} / (WACC − g_terminal)
                    = $84.80B / (9.0% − 2.5%)
                    = $1.30T

PV(TV)              = TV / (1 + WACC)^10
                    = $1.30T / 2.367
                    = $551.09B
            

9 · Reconciliation check (DCF PV vs. the market)

This isn't a fair value — it's the inverse check. The solver built the scenario so that DCF PV reproduces the current enterprise value; if the normal bracket worked the delta below is ~0 by construction. A non-zero delta only appears when the solver fell through to the widened margin band.

Σ PV(FCF_1..10) = -$395.15B
+ PV(TV)          = $551.09B
= Enterprise value = $155.93B   (widened solve — may differ from EV target)
− Total debt      = $14.30B
+ Cash            = $3.50B
= Equity value    = $145.13B
÷ Diluted shares  = 661.20B
= DCF PV / share  = $0.22

Market price      = $49.66
Reconciliation Δ  = −99.6%   (widened band — residual gap the scenario could not close)
            
Open this scenario in the calculator →
Every input above is pre-filled; the calculator auto-runs and lets you override any assumption.

Every rule above — growth-source priority, plateau tiers, compound cap, solver ladder, flag colours — is documented on the expectations scenario methodology.

What these ratios mean & how they're built: see the valuation ratios glossary on the company-facts methodology page — per-ratio definitions and the exact us-gaap concepts behind each numerator and denominator.

Sources. Denominators come from SEC EDGAR XBRL filings for FITB (CIK 0000035527); analyst growth forecasts come from analyst consensus. Share price is the latest split-adjusted close from our daily history (live quote as fallback). Per-share denominators are split-adjusted to today's share count.